Rituximab, Temozolomide, and Methylprednisolone in Treating Patients With Recurrent Primary CNS Non-Hodgkin's Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Temozolomide
Related studies linked through entity extraction aliases.
Temozolomide During and After Radiation Therapy in Treating Patients Who Have Undergone Previous Surgery and Placement of Gliadel Wafers for Newly Diagnosed Glioblastoma Multiforme
- Status
- TERMINATED
- Phase
- PHASE2
Radiation Therapy Combined With Either Gefitinib or Temozolomide in Pats With NSCLC and Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide & RT Followed by Dose Dense vs Temozolomide & Retinoic Acid in Pts w/Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Continuous Temozolomide in Patients With Advanced or Metastatic Soft Tissue Sarcoma or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Radiation Therapy or Temozolomide in Treating Patients With Gliomas
- Status
- COMPLETED
- Phase
- PHASE3
Prolonged Daily Temozolomide for Low-Grade Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Bevacizumab in Combination With Temozolomide in Patients With Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide and Topotecan in Treating Patients With Primary CNS Lymphoma
- Status
- WITHDRAWN
- Phase
- NA
S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Lonafarnib and Temozolomide in Treating Patients with Glioblastoma Multiforme That is Recurrent or Did Not Respond to Previous Treatment with Temozolomide
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas
- Status
- COMPLETED
- Phase
- PHASE2
Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE2
Thalidomide and Temozolomide in Relapsed or Progressive CNS Disease or Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Primary CNS Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide and VNP40101M in Treating Patients With Relapsed or Refractory Leukemias
- Status
- COMPLETED
- Phase
- PHASE1